Overjet Valuation, Funding & Investors

Overjet is valued at $712M as of December 2025.

Last Overjet valuation

$712M

Undisclosed stage · Dec 2025

Last Overjet funding round

$25M

Undisclosed stage · Dec 2025

Cumulative funding Overjet raised

$156M

across 5 funding rounds

Key investors in Overjet

  • Crosslink Capital
  • E14 Fund
  • General Catalyst
  • Insight Partners
  • Liquid 2 Ventures
  • SpringRock Ventures

Overjet Overview

About Overjet

Overjet is a Boston-based dental artificial intelligence company offering FDA-cleared software for radiographic analysis and clinical decision support. The platform detects caries, bone loss, and pathologies on X-rays with diagnostic codes linked to insurance standards, integrating with practice management systems like Dentrix and OpenDental. Overjet partners with payers such as Delta Dental and serves thousands of dental offices nationwide.


Founded

2018

HQ

United StatesBoston, MA

Status

Privately held

Customer focus

B2B

Revenue model

Subscription

Valuation

$712M (Dec 2025)

Overjet Valuation

Overjet is currently valued at $712M, based on its undisclosed-stage round in December 2025.

Overjet's valuation has grown 1.7x from $425M at its Series B in December 2021 to $712M in December 2025, across 3 priced rounds.

Overjet valuation by funding round

Overjet valuation by funding round
DateStageValuation
Dec 2025Undisclosed stage$712M
Mar 2024Series C$550M
Dec 2021Series B$425M

Overjet Funding History

Overjet has raised a total of $156M across 5 funding rounds.

Overjet's first fundraising round was a $8M seed round in June 2020. The most recent completed round was a $25M undisclosed-stage round in December 2025.

Overjet funding rounds

Overjet funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Dec 2025Undisclosed stage-$25M$712MOverjet is a Boston-based company specializing in dental AI software, founded by MIT and Harvard experts, providing FDA-cleared technology for disease detection, claims review, and improved efficiency for dentists and insurers serving over 73 million Americans. The company has raised over $130-155 million across multiple rounds, with key prior financings including a $42.5 million Series B in December 2021 at $425 million valuation led by General Catalyst and Insight Partners, a $53.2 million Series C in March 2024 backed by March Capital and others, and smaller rounds like $24.6 million Series C-II on December 24-29, 2025, and an $800,000 seed filing on December 9, 2025. Overjet continues to expand in the dental AI market, partnering with 16 major carriers and focusing on clinician and insurer tools amid strong demand.
Mar 2024Series CMarch Capital (lead); General Catalyst; E14 Fund; Harmonic Growth Partners; Liquid 2 Ventures; SpringRock Ventures; American Dental Association; Insight Partners; Crosslink Capital$53M$550MOverjet, a Boston-based leader in dental AI, develops artificial intelligence solutions that detect, outline, and quantify oral diseases with millimeter precision, enhance clinical decision-making, improve patient communication, and reduce administrative overhead for dental providers and payers. The company serves thousands of dentists across private practices and major dental support organizations (DSOs) in North America, and partners with payers covering over 120 million members, including most of the top 10 U.S. dental insurers. Overjet's platform has received four FDA clearances, including for spotting tooth decay and gum disease, and has been recognized in Forbes AI 50 and Fast Company’s World’s Most Innovative Companies. On March 5, 2024, Overjet announced a $53.2 million Series C funding round, the largest ever investment in dental AI, led by March Capital with participation from General Catalyst, Insight Partners, E14 Fund, Crosslink Capital, SpringRock Ventures (also noted as Spring Rock Capital), Liquid 2 Ventures, Harmonic Growth Partners, and the American Dental Association. This round brings Overjet's total funding to approximately $133 million and increases its post-money valuation to $550 million. Investors highlighted Overjet's explosive growth and market leadership in dental AI, positioning it to revolutionize patient care through workflow automation for providers and payers. The proceeds will accelerate product development, expand AI capabilities, scale operations, and unify the dental care ecosystem to make dentistry more patient-centric and establish an AI-enabled standard of care. Founded in 2018, Overjet aims to make dental AI ubiquitous, with quotes from CEO Wardah Inam and March Capital Partner Solomon Hailu emphasizing its role in elevating care standards and catalyzing expansion.
Dec 2021Series BGeneral Catalyst (lead); Insight Partners (lead); E14 Fund; Crosslink Capital$43M$425MOverjet develops dental artificial intelligence software to support clinicians and insurers in improving patient oral healthcare, claims review, and operating efficiency. On December 20, 2021, the company raised $42.5 million in an oversubscribed Series B round led by General Catalyst and Insight Partners, with participation from existing investors Crosslink Capital and the MIT-affiliated E14 Fund. This followed a $27 million Series A in August 2021, bringing total funding to nearly $80 million at that time. The round achieved a post-money valuation of $425 million, up from $115 million in the prior Series A. Overjet's platform has seen strong adoption, with 16 major dental insurers as customers covering over 73 million Americans, up from 50 million at the Series A. The company serves both providers and payers, using AI for consistent claims processing and enhanced clinical decision-making. CEO Wardah Inam highlighted the demand from clinicians and insurers for the technology to transform oral healthcare. The funding supports expansion of practice operations, team growth, and next-generation technology development amid a backlog of launches. Investors like General Catalyst praised the team's rapid market traction and vision to build dentistry's intelligence layer. Overjet has continued raising capital post-Series B, including later rounds reaching over $155 million total by 2024, but the December 2021 Series B marked a valuation milestone for a dental AI company.
Aug 2021Series AGeneral Catalyst (lead); Insight Partners (lead); E14 Fund; Crosslink Capital$27M-Overjet is a dental AI company developing software for disease identification, claims review, and improved operating efficiency for dentists and insurers. It raised a $27 million Series A round on approximately August 26, 2021, led by General Catalyst and Insight Partners, with participation from Crosslink Capital and the MIT-affiliated E14 Fund. The round followed earlier funding and preceded a $42.5 million oversubscribed Series B in December 2021, which brought total funding to nearly $80 million and valued the company at $425 million post-money. Overjet had gained FDA clearance for its Dental Assist product and secured partnerships with dental practices and insurers covering millions of members by late 2021. Subsequent growth included a $53.2 million Series C in March 2024 led by March Capital, increasing valuation to $550 million and total funding to $133 million, with partnerships covering over 120 million members and thousands of dentists.
Jun 2020SeedCrosslink Capital (lead); E14 Fund; Liquid 2 Ventures; SpringRock Ventures; Neoteny$8M-Overjet is a dental technology company founded in 2018 that builds artificial intelligence software to improve patient care, disease detection in X-rays, and insurance claim reviews in dentistry. The company raised $7.85 million in a seed funding round on June 30, 2020, led by Crosslink Capital with participation from MIT E14 Fund and strategic dental industry partners.

Who has invested in Overjet?

10 investors have backed Overjet across its funding rounds, including Crosslink Capital, E14 Fund, General Catalyst, Insight Partners, Liquid 2 Ventures and SpringRock Ventures.

Lead investors include March Capital, General Catalyst, Insight Partners and Crosslink Capital.


Overjet Investors

Investors in Overjet by funding rounds participated
InvestorHQRoundsRoleFirst check
E14 FundUnited StatesUnited States4ParticipantJun 2020
Crosslink CapitalUnited StatesSan Francisco, CA4LeadJun 2020
General CatalystUnited StatesSan Francisco, CA3LeadAug 2021
Insight PartnersUnited StatesNew York City, NY3LeadAug 2021
Liquid 2 VenturesUnited StatesSan Francisco, CA2ParticipantJun 2020
SpringRock VenturesUnited StatesSeattle, WA2ParticipantJun 2020
Harmonic Growth PartnersUnited StatesWashington, DC1ParticipantMar 2024
March CapitalUnited StatesLos Angeles, CA1LeadMar 2024

This data is available for Pro users. Sign up to see all 10 Overjet investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Overjet

Overjet has acquired 1 company to date.

Last acquisition by Overjet was on June 8th 2021. Overjet acquired American Dental Examiners for undisclosed valuation.


Latest Acquisitions by Overjet

American Dental Examiners
Description
American Dental Examiners is a third-party reviewer of dental claims and utilization management services. The company holds nationwide licenses and employs a network of dentist and specialist reviewers for payers including major insurers. Headquartered in Chicago, Illinois, American Dental Examiners also advises on benefits design. Founded in 1980, it pioneered dental claims auditing in the US.
HQ CountryUnited States
HQ City
New York City, NY
Deal Date8 Jun 2021
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Overjet acquisitions and their M&A valuation multiples.

Start Free Trial

Overjet Competitors

Overjet competitors include listed companies like Sphere and Yidu Tech, and private ones like Tennr, Latent, Rad AI and Saviynt.

Public and private companies comparable to Overjet
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
TennrUnited StatesNew York City, NYPrivate--$605M-
LatentUnited StatesSan Francisco, CAPrivate--$600M-
Rad AIUnited StatesSan Francisco, CAPrivate--$525M-
SphereSouth KoreaSouth KoreaPublicly listed$70M$6M$813M6.9x
Yidu TechChinaChinaPublicly listed$122M($4M)$449M1.2x
SaviyntUnited StatesLos Angeles, CAPrivate$300M-$700M2.3x
Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Horizon Quantum$269K($5M)2287.8x-(125.2x)(33.0x)
Shenzhen Sunwin$20M($147M)37.7x-(5.0x)-
Beijing Deep Glint Tech$23M($29M)25.1x8.7x(19.8x)(80.2x)
B-Soft Co.$157M($37M)4.7x4.8x(20.0x)(20.0x)
Phreesia$481M$27M1.3x1.3x23.2x5.3x
PKSHA Technology$140M$47M4.1x2.4x12.2x10.7x
Beijing Haitian Ruisheng$56M$5M13.8x14.0x160.9x-
Unisound Ai Technology$181M($22M)3.0x2.1x(24.5x)(36.1x)

This data is available for Pro users. Sign up to see all Overjet competitors and their valuation data.

Start Free Trial

Common questions about Overjet

When was Overjet founded?Overjet was founded in 2018.
Where is Overjet headquartered?Overjet is headquartered in Boston, MA, United States.
Is Overjet publicly listed?No, Overjet is a private, VC-backed company.
What is Overjet's valuation?Overjet was last valued at $712M in its undisclosed-stage round in December 2025.
How much funding has Overjet raised?Overjet has raised $156M across 5 funding rounds.
What was Overjet's last funding round?Overjet's last funding round was a $25M undisclosed-stage round in December 2025.
Who are Overjet's investors?Overjet's investors include E14 Fund, Crosslink Capital, General Catalyst, Insight Partners, Liquid 2 Ventures, SpringRock Ventures, Harmonic Growth Partners, March Capital, American Dental Association and Neoteny.
Which companies are comparable to Overjet?Companies comparable to Overjet include Tennr, Latent, Rad AI, Sphere, Yidu Tech and Saviynt.
How many companies has Overjet acquired?Overjet has acquired 1 company, including American Dental Examiners.

See companies similar to Overjet

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial